Precise genome editing using CRISPR-Cas9 is a promising avenue for genetic disease research. However, off-target editing effects can complicate and slow research.
In this webinar, Dr. Matthew Coelho discusses findings recently published in Nature Communications, “CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs.”
In this webinar, he will:
For research use only. Not for use in diagnostic procedures. Unless otherwise agreed to in writing, IDT does not intend these products to be used in clinical applications and does not warrant their fitness or suitability for any clinical diagnostic use. Purchaser is solely responsible for all decisions regarding the use of these products and any associated regulatory or legal obligations.